The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease
Abstract
OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is associated with cardiovascular risk. The aim of this study was to determine the role of fatty liver in predicting coronary artery disease and clinical outcomes in patients undergoing coronary angiogram. METHODS: This was a prospective cohort study carried out in a University hospital. Consecutive patients who underwent coronary angiogram had ultrasound screening for fatty liver. Significant cardiovascular disease was defined as ≥50% stenosis in at least one coronary artery. The primary outcome was a composite end point comprising cardiovascular deaths, non-fatal myocardial infarction and the need for further coronary intervention during prospective follow-up. RESULTS: Among 612 recruited patients, 356 (58.2%) had fatty liver by ultrasonography, 318 (52.0%) had elevated serum alanine aminotransferase and 465 (76.0%) had significant coronary artery disease. Coronary artery disease occurred in 84.6% of patients with fatty liver and 64.1% of those without fatty liver (p<0.001). After adjusting for demographic and metabolic factors, fatty liver (adjusted OR 2.31; 95% CI 1.46 to 3.64) and alanine aminotransferase level (adjusted OR 1.01; 95% CI 1.00 to 1.02) remained independently associated with coronary artery disease. At a mean follow-up of 87±22 weeks, 30 (10.0%) patients with fatty liver and 18 (11.0%) patients without fatty liver reached the composite clinical end point (p=0.79). CONCLUSIONS: In patients with clinical indications for coronary angiogram, fatty liver is associated with coronary artery disease independently of other metabolic factors. However, fatty liver cannot predict cardiovascular mortality and morbidity in patients with established coronary artery disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Universal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Clinical Investigation Group: Paul W. Armstrong, C. (., Global Perspective Group: Philip A. Poole-Wilson, C. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,230
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Williams, C. D., Stengel, J., Asike, M. I., Torres, D. M., Shaw, J., Contreras, M., Landt, C. L., & Harrison, S. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,148
The utility of radiological imaging in nonalcoholic fatty liver disease
Saadeh, S., Younossi, Z. M., Remer, E. M., Gramlich, T., Ong, J. P., Hurley, M., Mullen, K. D., Cooper, J. N., & Sheridan, M. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35354 · Cited by 2,110
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Obesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806
Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chan, H. L.-Y., Le Bail, B., Choi, P. C.-L., Kowo, M., Chan, A. W.-H., Merrouche, W., et al. (2010) · Hepatology · doi:10.1002/hep.23312 · Cited by 1,322
Self-citationAscha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296
Norhammar, A., Tenerz, Å., Nilsson, G., Hamsten, A., Efendíc, S., Rydén, L., & Malmberg, K. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09089-x · Cited by 1,112
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Hamaguchi, M., Kojima, T., Takeda, N., Nakagawa, T., Taniguchi, H., Fujii, K., Omatsu, T., Nakajima, T., Sarui, H., Shimazaki, M., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-10-200511150-00009 · Cited by 1,062
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Musso, G., Gambino, R., De Michieli, F., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., & Pagano, G. (2003) · Hepatology · doi:10.1053/jhep.2003.50132 · Cited by 759
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
Rafiq, N., Bai, C., Fang, Y., Srishord, M., McCullough, A., Gramlich, T., & Younossi, Z. M. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.11.005 · Cited by 729
Gruberg, L., Weissman, N. J., Waksman, R., Fuchs, S., Deible, R., Pinnow, E. E., Ahmed, L. M., Kent, K. M., Pichard, A. D., Suddath, W. O., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01802-2 · Cited by 696
Wong, V. W.-S., Wong, G. L.-H., Choi, P. C.-L., Chan, A. W.-H., Li, M. K.-P., Chan, H.-Y., Chim, A. M.-L., Yu, J., Sung, J. J.-Y., & Chan, H. L.-Y. (2010) · Gut · doi:10.1136/gut.2009.205088 · Cited by 648
Self-citationEndothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20781 · Cited by 629
Targher, G., Bertolini, L., Rodella, S., Tessari, R., Zenari, L., Lippi, G., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc07-0349 · Cited by 579
Farrell, G. C., Chitturi, S., Lau, G. K., Sollano, J. D., & NAFLD, F. T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05002.x · Cited by 517
CORONARY REVASCULARIZATION WRITING GROUP, Patel, M. R., Dehmer, G. J., Hirshfeld, J. W., Smith, P. K., & Spertus, J. A. (2009) · Circulation · doi:10.1161/circulationaha.108.191768 · Cited by 448
Speliotes, E. K., Massaro, J. M., Hoffmann, U., Vasan, R. S., Meigs, J. B., Sahani, D. V., Hirschhorn, J. N., O'Donnell, C. J., & Fox, C. S. (2010) · Hepatology · doi:10.1002/hep.23593 · Cited by 433
Day, C. P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.017 · Cited by 395
Alanine Aminotransferase, γ-Glutamyltransferase, and Incident Diabetes
Fraser, A., Harris, R., Sattar, N., Ebrahim, S., Davey Smith, G., & Lawlor, D. A. (2009) · Diabetes Care · doi:10.2337/dc08-1870 · Cited by 385
Gastaldelli, A., Kozakova, M., Hφjlund, K., Flyvbjerg, A., Favuzzi, A., Mitrakou, A., & Balkau, B. (2009) · Hepatology · doi:10.1002/hep.22845 · Cited by 377
Ruhl, C. E., & Everhart, J. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.052 · Cited by 352
Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease
Goessling, W., Massaro, J. M., Vasan, R. S., D'Agostino, R. B., Ellison, R. C., & Fox, C. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.018 · Cited by 330
Stepanova, M., Rafiq, N., & Younossi, Z. M. (2010) · Gut · doi:10.1136/gut.2010.213553 · Cited by 303
Ghouri, N., Preiss, D., & Sattar, N. (2010) · Hepatology · doi:10.1002/hep.23789 · Cited by 302
Index Event Bias as an Explanation for the Paradoxes of Recurrence Risk Research
Dahabreh, I. J. (2011) · JAMA · doi:10.1001/jama.2011.163 · Cited by 299
Fraser, A., Harris, R., Sattar, N., Ebrahim, S., Smith, G. D., & Lawlor, D. A. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.152298 · Cited by 277
High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis
Wong, V. W.-S., Wong, G. L.-H., Tsang, S. W.-C., Fan, T., Chu, W. C.-W., Woo, J., Chan, A. W.-H., Choi, P. C.-L., Chim, A. M.-L., Lau, J. Y.-W., et al. (2011) · Gut · doi:10.1136/gut.2011.237974 · Cited by 256
Self-citationBickel, C., Rupprecht, H. J., Blankenberg, S., Rippin, G., Hafner, G., Daunhauer, A., Hofmann, K.-P., & Meyer, J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02155-5 · Cited by 243
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Zoppini, G., Pichiri, I., Sorgato, C., Zenari, L., & Bonora, E. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.030 · Cited by 235
Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B
Wong, G. L.-H., Wong, V. W.-S., Choi, P. C.-L., Chan, A. W.-H., Chim, A. M.-L., Yiu, K. K.-L., Chan, H.-Y., Chan, F. K.-L., Sung, J. J.-Y., & Chan, H. L.-Y. (2009) · Gut · doi:10.1136/gut.2008.157735 · Cited by 229
Self-citationIoannou, G. N., Weiss, N. S., Boyko, E. J., Mozaffarian, D., & Lee, S. P. (2006) · Hepatology · doi:10.1002/hep.21171 · Cited by 220
Metabolic and Adipokine Profile of Chinese Patients With Nonalcoholic Fatty Liver Disease
Wong, V. W., Hui, A. Y., Tsang, S. W., Chan, J. L., Tse, A. M., Chan, K., So, W., Cheng, A. Y., Ng, W., Wong, G. L., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.06.011 · Cited by 200
Self-citationPresence of Coronary Plaques in Patients with Nonalcoholic Fatty Liver Disease
Assy, N., Djibre, A., Farah, R., Grosovski, M., & Marmor, A. (2010) · Radiology · doi:10.1148/radiol.09090769 · Cited by 192
McKimmie, R. L., Daniel, K. R., Carr, J. J., Bowden, D. W., Freedman, B. I., Register, T. C., Hsu, F.-C., Lohman, K. K., Weinberg, R. B., & Wagenknecht, L. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02188.x · Cited by 189
Choi, S.-Y., Kim, D., Kim, H. J., Kang, J. H., Chung, S. J., Park, M. J., Kim, Y. S., Kim, C. H., Choi, S. H., Kim, W. K., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.238 · Cited by 127
Wong, V. W., Hui, A., Tsang, S. W., Chan, J. L.-Y., Wong, G. L., Chan, A. W. H., So, W., CHENG, A. Y. S., Tong, P. C. Y., Chan, F. K. L., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03112.x · Cited by 92
Self-citationLiver: an alarm for the heart?
Mirbagheri, S. A., Rashidi, A., Abdi, S., Saedi, D., & Abouzari, M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01531.x · Cited by 78
Postprandial Lipemia Associates with Liver Fat Content
Matikainen, N., Mänttäri, S., Westerbacka, J., Vehkavaara, S., Lundbom, N. M. I., Yki‐Järvinen, H., & Taskinen, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0187 · Cited by 77
How should we manage patients with non‐alcoholic fatty liver disease in 2007?
Chan, H. L., de Silva, H. J., Leung, N. W. Y., Lim, S. G., Farrell, G. C., & NAFLD, T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04977.x · Cited by 74
Self-citationInteraction of Adipokines and Hepatitis B Virus on Histological Liver Injury in the Chinese
Wong, V. W., Wong, G. L., Yu, J. Q., Choi, P. C., Chan, A. W. H., Chan, H., Chu, E. S., Cheng, A. S. L., Chim, A. M., Chan, F. K. L., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.560 · Cited by 71
Self-citationWong, V. W., Wong, G. L., Tsang, S. W., Hui, A., Chan, A. W. H., Choi, P. C., So, W., Tse, A. M. L., Chan, F. K. L., Sung, J. J. �., et al. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05344.x · Cited by 66
Self-citationThe liver and the waistline: Fifty years of growth
Farrell, G. C. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06080.x · Cited by 54
Prior Aspirin Use and Outcomes in Acute Coronary Syndromes
Rich, J. D., Cannon, C. P., Murphy, S. A., Qin, J., Giugliano, R. P., & Braunwald, E. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.028 · Cited by 47
Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease
Targher, G., & Day, C. P. (2010) · Hepatology · doi:10.1002/hep.23901 · Cited by 16
Cited by
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,424
Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021
Vos, M. B., Abrams, S. H., Barlow, S. E., Caprio, S., Daniels, S. R., Kohli, R., Mouzaki, M., Sathya, P., Schwimmer, J. B., Sundaram, S. S., et al. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001482 · Cited by 1,008
Metadata
- Authors
- Wong, V. W.-S., Wong, G. L.-H., Yip, G. W.-K., Lo, A. O.-S., Limquiaco, J., Chu, W. C.-W., Chim, A. M.-L., Yu, C.-M., Yu, J., Chan, F. K.-L., Sung, J. J.-Y., & Chan, H. L.-Y.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2011-05-20
- Volume
- 60
- Issue
- 12
- Pages
- 1721-1727
- ISSN
- 0017-5749 (ISSN-L)
- OpenAlex
- W2096126171
- Cited by
- 296
- References
- 49
- FWCI
- 15.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.